Why Evolve IP Is Set For Lift-Off, As A Bright New Era Begins
New leadership, fresh focus — Evolve IP gears up for global impact.
News
1 min read
Cooley: IPO Leadership Continues
10 Nov, 2017
Palo Alto – November 6, 2017 – According to data from IPO Vital Signs and Pitchbook, Cooley is the #1 ranked law firm for VC-backed IPOs across all industries in the first three quarters of 2017. Additionally, Cooley ranks #1 for all technology and life sciences IPOs and #2 for all IPOs across all industries in the same period. Through the first three quarters of 2017, Cooley has advised on 97 completed capital markets transactions, including 22 IPOs. Cooley most recently advised US tech issuers Roku
on its $252 million IPO, MongoDB
on its $221 million IPO and Aquantia on its $61 million IPO. Cooley also most recently advised UK life sciences issuer
Nightstar Therapeutics on its $86 million IPO, and the underwriters on UK life sciences issuer
NuCana's $114 million IPO, US life science issuer Optinose’s $138 million IPO and US life sciences issuer OrthoPediatrics on its $60 million IPO. This is in addition to a significant number of issuer- and underwriter-side follow-on offerings upon which Cooley has recently advised. These are the latest examples of the firm’s commitment to and leadership in global capital markets.
About Cooley LLP Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has 900 lawyers across 12 offices in the United States, China and Europe.
